Prelude Capital Management’s Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 PNTM.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-39,001
Closed -$6.7K 1479
2023
Q1
$6.7K Sell
39,001
-700
-2% -$154 ﹤0.01% 1081
2022
Q4
$3.18K Sell
39,701
-15,827
-29% -$856 ﹤0.01% 1229
2022
Q3
$3K Hold
55,528
﹤0.01% 1410
2022
Q2
$7K Hold
55,528
﹤0.01% 1611
2022
Q1
$18K Hold
55,528
﹤0.01% 1554
2021
Q4
$49K Buy
55,528
+3,098
+6% +$2.49K ﹤0.01% 1784
2021
Q3
$38K Hold
52,430
﹤0.01% 1568
2021
Q2
$52K Buy
+52,430
New +$43.3K ﹤0.01% 1517

Prelude Capital Management's PNTM.WS Position: Q2 2023 in Review

Prelude Capital Management sold out of Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (PNTM.WS) in Q2 2023, closing a stake of 39,001 shares — an estimated $6.7K sold.

Prelude Capital Management first reported a position in PNTM.WS in Q2 2021 and held it in 8 quarters. The position peaked at $52K in Q2 2021. 0 funds tracked by Wall St. Rank hold PNTM.WS as of Q2 2023.

  • Prelude Capital Management reported no remaining Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • Prelude Capital Management sold 39,001 Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2023, an estimated $6.7K.
  • Prelude Capital Management first reported a position in Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2021 and held it in 8 quarters.
  • Prelude Capital Management's Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $52K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2023.

Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.